Quantitative assessment of diabetic peripheral neuropathy with use of the clanging tuning fork test

Endocrine Practice

Volumn 13, Issue 1, 2007, Pages 5-10

  Oyer, David S ^a   Saxon, David ^b   Shah, Ajul ^c  

^a NORTHWESTERN UNIVERSITY   (United States)

^b WASHINGTON UNIVERSITY   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETIC FOOT; DIABETIC NEUROPATHY; HUMAN; INSTRUMENTATION; INSULIN DEPENDENT DIABETES MELLITUS; METHODOLOGY; NEUROLOGIC EXAMINATION; NON INSULIN DEPENDENT DIABETES MELLITUS; PERCEPTIVE THRESHOLD; RANDOMIZED CONTROLLED TRIAL; REPRODUCIBILITY; STANDARD; VIBRATION;

ADULT; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC FOOT; DIABETIC NEUROPATHIES; DIAGNOSTIC TECHNIQUES, NEUROLOGICAL; HUMANS; NEUROLOGIC EXAMINATION; REPRODUCIBILITY OF RESULTS; SENSORY THRESHOLDS; VIBRATION;

EID: 34147092179     PISSN: 1530891X     EISSN: None     Source Type: Journal    
DOI: 10.4158/EP.13.1.5     Document Type: Article

References (19)

1. Boulton AJ, Vinik AI, Arezzo JC, et al (American Diabetes Association). Diabetic neuropathies: a statement by the American Diabetes Association. Diabetes Care. 2005;28:956-962.
2. Polydefkis M, Griffin JW, McArthur J. New insights into diabetic polyneuropathy. JAMA. 2003;290:1371-1376.
3. Valk GD, de Sonnaville JJ, van Houtum WH, et al. The assessment of diabetic polyneuropathy in daily clinical practice: reproducibility and validity of Semmes Weinstein monofilaments examination and clinical neurological examination. Muscle Nerve. 1997;20:116-118.
4. Perkins BA, Bril V. Early vascular risk factor modification in type 1 diabetes [erratum in N Engl J Med. 2005; 352:950]. N Engl J Med. 2005;352:408-409.
5. Singleton JR, Smith AG, Bromberg MB. Painful sensory polyneuropathy associated with impaired glucose tolerance. Muscle Nerve. 2001;24:1225-1228.
6. Novella SP, Inzucchi SE, Goldstein JM. The frequency of undiagnosed diabetes and impaired glucose tolerance in patients with idiopathic sensory neuropathy. Muscle Nerve. 2001;24:1229-1231.
7. Mayfield JA, Sugarman JR. The use of the Semmes-Weinstein monofilament and other threshold tests for preventing foot ulceration and amputation in persons with diabetes. J Fam Pract. 2000;49(11 Suppl):S17-S29.
8. Perkins BA, Bril V. Diabetic neuropathy: a review emphasizing diagnostic methods. Clin Neurophysiol. 2003;114:1167-1175.
9. Boulton AJ, Malik RA, Arezzo JC, Sosenko JM. Diabetic somatic neuropathies. Diabetes Care. 2004;27: 1458-1486.
10. Young MJ, Breddy JL, Veves A, Boulton AJ. The prediction of diabetic neuropathic foot ulceration using vibration perception thresholds: a prospective study. Diabetes Care. 1994;17:557-560.
11. Kastenbauer T, Sauseng S, Sokol G, Auinger M, Irsigler K, et al. A prospective study of predictors for foot ulceration in type 2 diabetes. J Am Podiatr Med Assoc. 2001;91:343-350.
12. Meijer JW, Smit AJ, Lefrandt JD, van der Hoeven JH, Hoogenberg K, Links TP. Back to basics in diagnosing diabetic polyneuropathy with the tuning fork! Diabetes Care. 2005;28:2201-2205.
13. Perkins BA, Olaleye D, Zinman B, Bril V. Simple screening tests for peripheral neuropathy in the diabetes clinic. Diabetes Care. 2001;24:250-256.
14. Bril V, Perkins BA. Validation of the Toronto Clinical Scoring System for diabetic polyneuropathy. Diabetes Care. 2002;25:2048-2052.
15. Kastenbauer T, Sauseng S, Brath H, Abrahamian H, Irsigler K. The value of the Rydel-Seiffer tuning fork as a predictor of diabetic polyneuropathy compared with a neurothesiometer. Diabet Med. 2004;21:563-567.
16. Hilz MJ, Axelrod FB, Hermann K, Haertl U, Duetsch M, Neundorfer B. Normative values of vibratory perception in 530 children, juveniles and adults aged 3-79 years. J Neurol Sci. 1998;159:219-225.
17. Oyer DS, Shah A. Vibration perception vs age in non-diabetic patients [abstract #343]. Endocr Pract. 2006;12 (Addendum to Suppl 2):9.
18. Smith KD, Emerzian GJ, Petrov O. A comparison of calibrated and non-calibrated 5.07 nylon monofilaments. Foot Ankle Int. 2000;21:852-855.
19. McCabe CJ, Stevenson RC, Dolan AM. Evaluation of a diabetic foot screening and protection programme. Diabet Med. 1998;15:80-84.